01—Abstract
Summary
Summary of the 10-Q filed November 4, 2024. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group (UNH) reported a solid third quarter with revenues reaching $100.82 billiona, a 9% increase year-over-year, driven by strong performance in both the UnitedHealthcare and Optum segments.
UnitedHealthcare saw a 7% revenue increase, primarily due to growth in Medicare Advantage and domestic commercial offerings, although this was partially offset by Medicaid redeterminations and Medicare funding pressures. The Optum segment delivered a robust 13% revenue growth, spearheaded by Optum Rx and Optum Health, demonstrating the company's diversified growth strategy. While net earnings attributable to common shareholders saw a decrease of 48% to $8.86 billionb for the nine months ended September 30, 2024, largely influenced by a significant $7.1 billion loss from the sale of Brazil operations and a $1.2 billion loss from classifying remaining South American operations as held for sale, the company's operational performance remains resilient.
The company also continues to navigate the ongoing impacts of the Change Healthcare cyberattack, incurring response costs and business disruption impacts, though mitigation efforts are progressing. UNH remains committed to returning capital to shareholders through dividends and share repurchases, with an increased quarterly dividend declared.
02—Key points
Key Highlights
- Total revenues increased by 9% to $100.82 billion for the third quarter, driven by both UnitedHealthcare and Optum segments.
- UnitedHealthcare revenues grew 7% to $74.85 billion, supported by expansion in Medicare Advantage and domestic commercial business, serving 2.0 million more people domestically.
- Optum segment revenues surged by 13% to $63.93 billion, with Optum Rx and Optum Health showing strong double-digit growth.
- Net earnings attributable to common shareholders for the nine months ended September 30, 2024, were $8.86 billion, a decrease from $16.93 billion in the prior year, impacted by significant losses from the divestiture of Brazil operations ($7.1 billion) and South American operations held for sale ($1.2 billion).
- The company incurred $1.7 billion in direct response costs and business disruption impacts related to the Change Healthcare cyberattack for the nine months ended September 30, 2024.
- Cash flows from operations for the nine months ended September 30, 2024, were $21.8 billion, a decrease from $34.3 billion in the prior year, affected by cyberattack response actions and timing of CMS payments.
- The quarterly cash dividend was increased to an annual rate of $8.40 per share, reflecting confidence in ongoing financial performance and commitment to shareholder returns.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2024, UnitedHealth Group Inc kept $0.06.
- Revenue$100.82B100.0%
- Cost of revenue−$11.83B11.7%
- Gross profit$88.99B88.3%
- Operating costs−$80.28B79.6%
- Operating income$8.71B8.6%
- Interest, other & tax−$2.65B2.6%
- Net income$6.05B6.0%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed November 4, 2024Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $100.82B$92.36B | +9.2% |
| Cost of Revenue | $11.83B$9.42B | +25.6% |
| Gross Profit | $88.99B$82.94B | +7.3% |
| SG&A Expenses | $13.28B$13.86B | −4.2% |
| Operating Expenses | $92.11B$83.83B | +9.9% |
| Operating Income | $8.71B$8.53B | +2.1% |
| Interest Expense | $1.07B$834.00M | +28.8% |
| Net Income | $6.05B$5.84B | +3.7% |
| EPS (Basic) | $6.56$6.31 | +4.0% |
| EPS (Diluted) | $6.51$6.24 | +4.3% |
| Shares Outstanding (Basic) | 923.00M926.00M | −0.3% |
| Shares Outstanding (Diluted) | 930.00M936.00M | −0.6% |
05—Questions
Frequently Asked Questions
What was the primary driver of the significant decrease in net earnings for the nine months ended September 30, 2024?
The substantial decrease in net earnings was primarily due to significant losses recognized from divestitures, specifically a $7.1 billion loss from the sale of its Brazil operations and a $1.2 billion loss from classifying its remaining South American operations as held for sale.
How is the Change Healthcare cyberattack impacting UnitedHealth Group's financial performance?
The Change Healthcare cyberattack has resulted in direct response costs and business disruption impacts. For the nine months ended September 30, 2024, the company incurred $1.7 billion in such costs, including support for care providers and lost revenue for Optum Insight. These impacts are expected to continue, albeit at a lesser extent, into 2025.
What is the outlook for UnitedHealthcare's Medicare Advantage business?
UnitedHealthcare's Medicare Advantage business is facing pressure due to Medicare funding reductions and substantial revisions to the risk adjustment model. These factors are expected to result in reduced funding and potentially impact benefits for beneficiaries, particularly those with greater health challenges. The company is implementing strategies to mitigate these pressures, including cost management and network adjustments.
How is the company managing its liquidity and capital resources?
The company maintains strong liquidity with $32.4 billion in cash and cash equivalents as of September 30, 2024, with $5.2 billion available for general corporate use. They are actively managing capital through share repurchases, dividend payments, and strategic debt issuance. The company also announced an increase in its quarterly cash dividend, demonstrating confidence in its financial stability.
06—Continue